Niederer Kraft Frey (NKF) advised Alpiq Holding on a revolving credit facilities agreement with an international syndicate of banks as lenders and a revolving loan facility agreement with a syndicate of Swiss banks as lenders. UBS Switzerland, advised by Homburger, acted as mandated lead arranger and sole bookrunner in relation to such financings. The credit […]
Homburger advised Alchemy US on the renewal of its credit financings. The firm entered into a term loan credit agreement with HPS Investment as a term loan agent. The firm also entered into an asset-based
Swiss biotech company Alentis Therapeutics has successfully closed a $181.4 million oversubscribed Series D financing round, supported by a syndicate of top-tier biotech investors. The financing will support the company to develop a deep pipeline of
Homburger served as legal advisor to UBS Switzerland AG and other syndicate banks in connection with the financing of Deutsche Private Equity’s (DPE) acquisition of IMPAG Group. UBS acted as mandated lead arranger, underwriter,
Homburger advised Elanco in Switzerland on any aspect of Swiss law within the transaction. The background On the 13th of August 2024, Elanco Animal Health and Elanco US entered into an incremental assumption agreement to obtain
Homburger acted as counsel to SMBC Group in its capacity as documentation agent in connection with an English law-governed JPY 42,000 million (around CHF 250 million) sustainability-linked Samurai loan with Axpo Holding as borrower and an international
Homburger, on October 24, 2024, advised Avolta on a refinancing deal of its revolving credit facility (RCF). The amended EUR 2,400 m RCF with maturity in 2029 replaces the EUR 2,750 m RCF expiring in 2027. Avolta Avolta is a Swiss-based
Kellerhals Carrard advised Panakes Partners in leading the EUR 17.9 million Series B financing round of Lymphatica Medtech. This round was co-led by TechWald Holding S.p.A., and CDP Venture Capital SGR, with participation from
Niederer Kraft Frey (NKF) advised CREAL SA on its successful Series B Prime financing round, which was led by Carl Zeiss Vision International GmbH. NKF also advised CREAL on a strategic license agreement with ZEISS,
Homburger has advised Hevolution Foundation on its participation in a Series A investment round in Vandria, which raised a total of USD 30.7 million. Hevolution Foundation, a global non-profit organisation dedicated to advancing health span science
